If you had seen Evolv Technologies win multi year deals with schools, hospitals and sports venues, it might have been tempting to lean into the bullish analyst targets. For Evolv Technologies shareholders, the loss over the past year was 39.3%, including dividends. That gap between upbeat August 2025 forecasts and what actually happened raises a sharper question. Which assumption on record back then would you have pressed hardest before accepting that growth story?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
Evolv Technologies is not the only name tied to this theme. Zero in on 39 AI small caps and compare how each one is priced.
The shares cost US$7.73 at the start of the period, and anyone looking at Evolv Technologies then had to choose which story felt more realistic.
The bullish narrative pinned fair value at US$9.50, based on an assumption that revenue could climb 19.8% a year and that multi year contracts with schools and hospitals would help lift the profit margin to 9.0% and support a future P/E of 126.9x within three years.
The bearish view set fair value at US$5.50, assumed 18.1% annual revenue growth and warned that rising regulatory and privacy pressure on AI security screening could constrain pricing power even if the profit margin reached 8.8% and the future P/E ended up at 77.2x.
Evolv Technologies secured new and renewed multi year venue agreements, such as TD Garden and the Delta Center, and gained SAFETY Act Designation for eXpedite, which supported the bullish assumption about wider adoption and contract depth. Reported Q2 2026 revenue of US$43.8 million and a narrower net loss supported progress, while a net margin of 21.3% below zero kept the profitability part of the optimistic case unproven. Overall, the evidence cut both ways.
The live test here was simple: assumptions about multi year subscription reach and margin improvement need checking against future revenue, annual recurring revenue and the actual net margin, not just headlines about new deployments.
Today Evolv Technologies trades at US$4.61, with this Narrative’s Fair Value sitting above that quote based on its own assumptions rather than hard fact. The argument leans on low penetration of serviceable doorways, recurring contracts and an AI data moat, set against supply chain and margin friction.
On that view, anyone paying today’s price would need to believe Evolv can turn its expanding installed base and subscription model into materially stronger cash generation while absorbing inventory swings, refurbishment costs and component pressures.
"The main condition for success is that Evolv converts its under 5% penetration of an estimated 700,000 serviceable doorways and growing multi-vertical footprint into long-lived subscription contracts supported by its AI data moat and manufacturing scale. The current numbers on revenue growth, annual recurring revenue, remaining performance obligation and margin improvement imply a share price that does not fully reflect the company’s cash flow positive status, recurring revenue base and the management plan to reach over US$500m revenue with at least 25% adjusted EBITDA margins by 2031."
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for
Evolv Technologies leans heavily on AI at the physical edge. Your attention naturally goes there first.
Step sideways and there is a different AI angle. One business is trying to turn personal devices into an AI hub that quietly handles more of your daily decisions.
Instead of venue security, the focus is on tightly linked hardware and paid digital services that live on top of that hardware.
That setup needs powerful chips, tailored software and reasons for users to keep paying.
If it works, everyday phones, watches and home gadgets could feel more like subscription gateways than one off purchases.
It is written up in full, assumptions and all. → Explore the Narrative that puts this company 19% above its price
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com